1-111348616-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_181643.6(PIFO):āc.359A>Cā(p.Lys120Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,459,346 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_181643.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PIFO | NM_181643.6 | c.359A>C | p.Lys120Thr | missense_variant | 4/6 | ENST00000369738.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CIMAP3 | ENST00000369738.9 | c.359A>C | p.Lys120Thr | missense_variant | 4/6 | 1 | NM_181643.6 | P2 | |
CIMAP3 | ENST00000369737.4 | c.260A>C | p.Lys87Thr | missense_variant | 3/5 | 2 | A2 | ||
CIMAP3 | ENST00000468395.1 | n.276A>C | non_coding_transcript_exon_variant | 1/3 | 2 | ||||
CIMAP3 | ENST00000484512.1 | n.412A>C | non_coding_transcript_exon_variant | 4/5 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000403 AC: 1AN: 248266Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134334
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1459346Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 726012
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 16, 2024 | The c.359A>C (p.K120T) alteration is located in exon 4 (coding exon 4) of the PIFO gene. This alteration results from a A to C substitution at nucleotide position 359, causing the lysine (K) at amino acid position 120 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at